Novel combinations of antibiotics to inhibit extended-spectrum β-lactamase and metallo-β-lactamase producers in vitro: A synergistic approach

Future Microbiology

Volumn 8, Issue 7, 2013, Pages 939-944

  Hasan, Sadaf ^a   Ali, Saeedut Zafar ^a   Khan, Asad U ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

cefoxitin; drug resistance; ESBL; NDM 1; synergy

Indexed keywords

ANTIBIOTIC AGENT; CEFOTAXIME; CEFOXITIN; EXTENDED SPECTRUM BETA LACTAMASE; METALLO BETA LACTAMASE; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BROTH DILUTION; DRUG EFFICACY; DRUG POTENTIATION; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BACTERIA; BETA-LACTAMASES; DRUG SYNERGISM; MICROBIAL SENSITIVITY TESTS;

EID: 84880119755     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.13.54     Document Type: Article

References (15)

1. Chakraborty D, Basu S, Das S. Study on some Gram negative multi drug resistant bacteria and their molecular characterization. Asian J. Pharm. Clin. Res. 4, 108-112 (2011).
2. Igbinosa EO, Odjadjare EE, Igbinosa IH, Orhue PO, Omoigberale NO, Amhanre NI. Antibiotic synergy interaction against multidrug-resistant Pseudomonas aeruginosa isolated from an abattoir effluent environment. ScientificWorldJournal 2012, 308034 (2012).
3. Celenzaa G, Segatorea B, Setaccia D et al. In vitro antimicrobial activity of pannarin alone and in combination with antibiotics against methicillin-resistant Staphylococcus aureus clinical isolates. Phytomedicine 19, 596-602 (2012).
4. Drago L, De Vecchi E, Nicola L, Gismondo MR. In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections. BMC Infect. Dis. 7, 111 (2007).
5. Shakil S, Akram M, Ali SM, Khan AU. Acquisition of extended-spectrum b-lactamase producing Escherichia coli strains in male and female infants admitted to a neonatal intensive care unit: molecular epidemiology and analysis of risk factors. J. Med. Microbiol. 59, 948-954 (2010).
6. Shakil S, Khan AU. Infected foot ulcers in male and female diabetic patients: a clinico-bioinformative study. Ann. Clin. Microbiol. Antimicrob. 9, 2 (2010).
7. Khan AU, Nordmann P. NDM-1-producing Enterobacter cloacae and Klebsiella pneumoniae from diabetic foot ulcers in India. J. Med. Microbiol. 61, 454-456 (2012).
8. Islam MA, Alam MM, Choudhury ME, Kobayashi N, Ahmed MU. Determination of minimum inhibitory concentration (MIC) of cloxacillin for selected isolates of methicillin-resistant Staphylococcus aureus (MRSA) with their antibiogram. Bangl. J. Vet. Med. 6, 121-126 (2008).
9. Hasan S, Danishuddin M, Adil M, Singh K, Verma PK, Khan AU. Efficacy of E. officinalis on the cariogenic properties of Streptococcus mutans: novel and alternative approach to suppress quorum-sensing mechanism. PLoS ONE 7, e40319 (2012).
10. White RL, Burgess DS, Manduru M, Bosso JA. Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test. Antimicrob. Agents Chemother. 4, 1914-1918 (1996).
11. Fisher J, Belasco JG, Khosla S, Knowles J. Beta-lactamase proceeds via an acyl-enzyme intermediate. Interaction of the Escherichia coli RTEM enzyme with cefoxitin. Biochemistry 19, 2895-2901 (1980).
12. Matagne A, Lamotte-Brasseur J, Dive G, Knox JR, Frere JM. Interactions between active-site-serine beta-lactamases and compounds bearing a methoxy side chain on the alpha-face of the beta-lactam ring: kinetic and molecular modelling studies. Biochem. J. 293, 607-611 (1993).
13. Nordmann P, Boulanger AE, Poirel L. NDM-4 metallo-b-lactamase with increased carbapenemase activity from Escherichia coli. Antimicrob. Agents Chemother. 56, 2184-2186 (2012).
14. Shakil S, Khan R, Zarrilli R, Khan AU. Aminoglycosides versus bacteria-a description of the action, resistance mechanism, and nosocomial battleground. J. Biomed. Sci. 15, 5-14 (2008).
15. Nakamura A, Hosoda M, Katoa T et al. Combined effects of meropenem and aminoglycosides on Pseudomonas aeruginosa in vitro. J. Antimicrob. Chemother. 46, 901-904 (2000).